Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NECROPTOSIS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
NECROPTOSIS is a concept in neurodegeneration research. Key relationships include: associated with, activates, co discussed. Associated with ALS, ALZHEIMER'S DISEASE, CANCER. Connected to 80 entities in the SciDEX knowledge graph.
| Name | NECROPTOSIS |
| Key Genes/Proteins | PARP12, RIPK1, RIPK3, TNF, MMP9, TAU |
| Related Diseases | AXONAL_DEGENERATION, NETS, CELL SURVIVAL, AGING |
| Related Pathways | NLRP3 INFLAMMASOME |
Knowledge base pages for this entity
flowchart TD
Necroptosis["Necroptosis"]
Als["Als"]
Cancer["Cancer"]
APOPTOSIS(["APOPTOSIS"])
INFLAMMATION(["INFLAMMATION"])
PYROPTOSIS(["PYROPTOSIS"])
FERROPTOSIS(["FERROPTOSIS"])
CANCER(["CANCER"])
RIPK3(["RIPK3"])
MLKL(["MLKL"])
Tumor["Tumor"]
Inflammation["Inflammation"]
AUTOPHAGY(["AUTOPHAGY"])
Als -->|"activates"| Necroptosis
Cancer -->|"therapeutic target"| Necroptosis
Als -->|"therapeutic target"| Necroptosis
APOPTOSIS -->|"regulates"| Necroptosis
INFLAMMATION -->|"activates"| Necroptosis
PYROPTOSIS -->|"regulates"| Necroptosis
FERROPTOSIS -->|"regulates"| Necroptosis
APOPTOSIS -->|"activates"| Necroptosis
CANCER -->|"therapeutic target"| Necroptosis
RIPK3 -->|"regulates"| Necroptosis
MLKL -->|"regulates"| Necroptosis
Cancer -->|"activates"| Necroptosis
Tumor -->|"activates"| Necroptosis
Inflammation -->|"activates"| Necroptosis
AUTOPHAGY -->|"regulates"| Necroptosis
style Necroptosis fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| AXONAL_DEGENERATION | causes | phenotype | 0.68 |
| TAU | causes | protein | 0.65 |
| NEURON | targets | cell_type | 0.65 |
| TNF | causes | gene | 0.65 |
| NLRP3 INFLAMMASOME | regulates | pathway | 0.65 |
| CELL SURVIVAL | stabilizes | phenotype | 0.65 |
| ASTROCYTES | activates | cell_type | 0.65 |
| NLRP3 INFLAMMASOME | interacts_with | pathway | 0.65 |
| AGING | causes | phenotype | 0.65 |
| MLKL | activates | gene | 0.65 |
| EPILEPSY | protects_against | disease | 0.65 |
| RIPK1 | phosphorylates | gene | 0.65 |
| RIPK1 | treats | gene | 0.65 |
| CORTEX | activates | brain_region | 0.65 |
| CORTEX | regulates | brain_region | 0.65 |
| ASTROCYTE | protects_against | cell_type | 0.65 |
| ASTROGLIOSIS | inhibits | phenotype | 0.65 |
| RIPK1 | targets | gene | 0.65 |
| MICROGLIA | regulates | cell_type | 0.65 |
| AMYLOID | degrades | protein | 0.65 |
| NEUROINFLAMMATION | exacerbates | phenotype | 0.65 |
| NEUROINFLAMMATION | interacts_with | phenotype | 0.65 |
| INFLAMMATION | degrades | phenotype | 0.65 |
| DYSMYELINATION | causes | phenotype | 0.64 |
| AMYOTROPHIC LATERAL SCLEROSIS | implicated_in | disease | 0.55 |
| TNF | implicated_in | gene | 0.55 |
| CORTEX | expressed_in | brain_region | 0.55 |
| INFLAMMATION | participates_in | phenotype | 0.55 |
| STROKE | implicated_in | disease | 0.55 |
| AMYLOID | participates_in | protein | 0.55 |
| AXONAL DEGENERATION | implicated_in | phenotype | 0.55 |
| AXONAL DEGENERATION | participates_in | phenotype | 0.55 |
| AMYLOID | implicated_in | protein | 0.55 |
| PYROPTOSIS | co_discussed | entity | 0.50 |
| RIPK1 | co_discussed | entity | 0.50 |
| RIPK3 | co_discussed | entity | 0.50 |
| STING | co_discussed | entity | 0.50 |
| RIPK1 | associated_with | gene | 0.50 |
| PYROPTOSIS | involved_in | process | 0.50 |
| PYROPTOSIS | regulates | process | 0.50 |
| MITOPHAGY | associated_with | process | 0.50 |
| INSULIN RESISTANCE | inhibits | process | 0.50 |
| METFORMIN | associated_with | drug | 0.45 |
| MELATONIN | associated_with | drug | 0.45 |
| INFLAMMATION | activates | process | 0.44 |
| FERROPTOSIS | activates | process | 0.44 |
| FERROPTOSIS | associated_with | process | 0.44 |
| INFLAMMATION | regulates | process | 0.44 |
| AUTOPHAGY | associated_with | process | 0.44 |
| TRAUMATIC BRAIN INJURY | co_discussed | disease | 0.40 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PARP12 | regulates | gene | 0.80 |
| RIPK1 | activates | protein | 0.72 |
| RIPK3 | activates | protein | 0.72 |
| TNF | triggers | protein | 0.70 |
| MMP9 | activates | protein | 0.68 |
| NETS | regulates | phenotype | 0.68 |
| NEURON | interacts_with | cell_type | 0.65 |
| FOXO1 | inhibits | gene | 0.65 |
| FOXO1 | interacts_with | gene | 0.65 |
| RIPK1 | degrades | gene | 0.65 |
| MMP9 | treats | gene | 0.65 |
| EXCITOTOXICITY | activates | phenotype | 0.65 |
| OXIDATIVE PHOSPHORYLATION | causes | phenotype | 0.65 |
| VALPROIC ACID | activates | drug | 0.65 |
| VALPROIC ACID | inhibits | drug | 0.65 |
| COGNITIVE DECLINE | inhibits | phenotype | 0.65 |
| WHITE MATTER | regulates | brain_region | 0.65 |
| MLKL | treats | gene | 0.65 |
| MICROGLIAL ACTIVATION | regulates | phenotype | 0.65 |
| MLKL | causes | gene | 0.65 |
| DIMETHYL FUMARATE | inhibits | drug | 0.65 |
| ER STRESS | activates | phenotype | 0.65 |
| ROS | increases_risk | phenotype | 0.65 |
| AXONAL DEGENERATION | regulates | phenotype | 0.65 |
| EXCITOTOXICITY | regulates | phenotype | 0.65 |
| ENDOPLASMIC RETICULUM STRESS | activates | phenotype | 0.65 |
| MLKL | participates_in | protein | 0.64 |
| MMP9_IN1 | inhibits | drug | 0.64 |
| MITOCHONDRIA | participates_in | cell_type | 0.64 |
| CELL DEATH | implicated_in | phenotype | 0.55 |
| MMP9 | implicated_in | gene | 0.55 |
| STROKE | expressed_in | disease | 0.55 |
| RIPK1 | implicated_in | gene | 0.55 |
| STING | implicated_in | gene | 0.55 |
| APOPTOSIS | co_discussed | entity | 0.50 |
| MLKL | co_discussed | entity | 0.50 |
| FERROPTOSIS | co_discussed | entity | 0.50 |
| BECN1 | co_discussed | entity | 0.50 |
| MMP9 | co_discussed | entity | 0.50 |
| AUTOPHAGY | co_discussed | entity | 0.50 |
| MITOCHONDRIA | co_discussed | entity | 0.50 |
| ENDOSOMAL SORTING | interacts_with | process | 0.50 |
| ALZHEIMER | associated_with | disease | 0.50 |
| PARKINSON | associated_with | disease | 0.50 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | disease | 0.50 |
| HUNTINGTON'S DISEASE | associated_with | disease | 0.50 |
| HUNTINGTON | associated_with | disease | 0.50 |
| MULTIPLE SCLEROSIS | associated_with | disease | 0.50 |
| STROKE | associated_with | disease | 0.50 |
| TRAUMATIC BRAIN INJURY | associated_with | disease | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||